Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Randomised Controlled Trial to Establish the Effects of Low-dose rtPA and the Effects of Early Intensive Blood Pressure Lowering in Patients With Acute Ischaemic Stroke

NCT01422616 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT01422616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01422616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Randomised Controlled Trial to Establish the Effects of Low-dose rtPA and the Effects of Early Intensive Blood Pressure Lowering in Patients With Acute Ischaemic Stroke
Lead sponsor
The George Institute
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
August 31, 2018
Enrollment
4,587 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high blood pressure, ischemic stroke